Adelaide, SOUTH%20AUSTRAILA4 Active Studies

Leukemia Clinical Trials in Adelaide, SOUTH%20AUSTRAILA

Find 4 actively recruiting leukemia clinical trials in Adelaide, SOUTH%20AUSTRAILA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
561
Enrolling

Recruiting Leukemia Studies in Adelaide

RecruitingAdelaide, SOUTH%20AUSTRAILANCT04521231

A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL

The Phase I part of the study aims to evaluate the safety, efficacy, and tolerability of subcutaneous (SC) blinatumomab for treatment of Relapsed or Refractory B cell Precursor Acute Lymphoblastic Leu...

281 participants
Amgen
View Study Details
RecruitingAdelaide, SOUTH%20AUSTRAILANCT06824168

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

This clinical two-arm trial is designed to evaluate two doses of quizartinib as maintenance therapy after induction/consolidation in participants with FMS-like tyrosine kinase 3 (FLT3)-internal tandem...

130 participants
Daiichi Sankyo
View Study Details
RecruitingAdelaide, SOUTH%20AUSTRAILANCT05756322

The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias

The most common types of acute leukaemia are acute lymphoblastic leukaemia (ALL) and acute myeloid leukaemia (AML). AML is a heterogenous clonal disorder of haemopoietic progenitor cells and the most ...

90 participants
Lin BioScience, Inc
View Study Details
RecruitingAdelaide, SOUTH%20AUSTRAILANCT06841055

Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy Following Chemoimmunotherapy

This is a Phase II, multisite, open-label, single arm study with two parts in participants with advanced/metastatic NSCLC which progressed after a first-line chemoimmunotherapy. Part 1 is safety run-...

60 participants
BioNTech SE
View Study Details

About Leukemia Clinical Trials in Adelaide

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 4 leukemia clinical trials recruiting participants in Adelaide, SOUTH%20AUSTRAILA. These studies are seeking a combined 561 participants. Research is being sponsored by Amgen, Daiichi Sankyo, Lin BioScience, Inc and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Adelaide — FAQ

Are there leukemia clinical trials in Adelaide?

Yes, there are 4 leukemia clinical trials currently recruiting in Adelaide, SOUTH%20AUSTRAILA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Adelaide?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Adelaide research site will contact you about next steps.

Are clinical trials in Adelaide free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Adelaide studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 4 active trials in Adelaide are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated March 2, 2026 from ClinicalTrials.gov